Company News
- CTD Holdings Announces Plans to Broaden its Expanded Access Program for Trappsol® Cyclo™
Oct 15, 2018, 8:00 AM EDT - CTD Holdings to Host Webinar on its Phase I Clinical Trial for Niemann-Pick Disease Type C
Oct 11, 2018, 12:57 PM EDT - CTD Holdings to Present at BioFlorida Conference with update on Clinical Program Using Cyclodextrins to treat diseases with Unmet Medical Needs
Oct 9, 2018, 12:03 PM EDT - CTD Holdings Establishes Second Clinical Trial Site for US Phase I Clinical Study of Trappsol® Cyclo™ for Treatment of Niemann-Pick Disease Type C
Oct 5, 2018, 8:00 AM EDT - CTD announces encouraging top-line data from two ongoing clinical trials of Trappsol® Cyclo™ administered intravenously in Niemann Pick Disease Type C (NPC)
Oct 3, 2018, 8:00 AM EDT - CTD Holdings to Present at UK Annual Conference for NPC Patients, Families, and Health Professionals
Sep 13, 2018, 10:56 AM EDT - CTD Holdings Discusses its Phase I Clinical Trial for Intravenous Use of Trappsol® Cyclo™ in Niemann-Pick Disease Type C
Aug 30, 2018, 12:11 PM EDT - CTD Holdings’ Trappsol® Cyclo™ Featured in Television Program on Niemann-Pick Disease Type C
Aug 23, 2018, 8:00 AM EDT - CTD Holdings Announces Expanded Access Protocol using Intravenous Trappsol® Cyclo™ for Alzheimer’s Disease
Aug 13, 2018, 8:00 AM EDT - CTD is working to establish a second clinical trial site at Morristown Medical Center, Atlantic Health System, Morristown, NJ
Aug 6, 2018, 8:00 AM EDT
